Trial Profile
A 21-Day, Randomized, Controlled Study to Evaluate the Irritation Potential of Diltiazem Hydrochloride 2% Cream in Healthy Subjects, Using a Cumulative Irritant Patch Test Design
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 13 Nov 2014
Price :
$35
*
At a glance
- Drugs Diltiazem (Primary)
- Indications Fissure in ano
- Focus Adverse reactions
- Sponsors Ventrus Biosciences
- 13 Nov 2014 New trial record